celecoxib has been researched along with Libman-Sacks Disease in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Herein, we report a case of systemic lupus erythematosus complicated with JA without bone erosion." | 1.72 | Case report: Joint deformity associated with systemic lupus erythematosus. ( Chen, SL; Lin, CS; Xu, Q; Zhang, LY; Zheng, HJ, 2022) |
| "Celecoxib treatment induced apoptosis of murine lupus T cells in vitro, which was inhibited by z-VAD-fmk, a pan-caspase inhibitor." | 1.34 | Apoptosis of murine lupus T cells induced by the selective cyclooxygenase-2 inhibitor celecoxib: molecular mechanisms and therapeutic potential. ( Gao, XM; Ping, L; Yang, P; Zhang, Y, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SL | 1 |
| Zheng, HJ | 1 |
| Zhang, LY | 1 |
| Xu, Q | 1 |
| Lin, CS | 1 |
| Fatemi, G | 1 |
| Kermani, TA | 1 |
| Wallace, DJ | 2 |
| Hersh, AO | 1 |
| von Scheven, E | 1 |
| Yazdany, J | 1 |
| Panopalis, P | 1 |
| Trupin, L | 1 |
| Julian, L | 1 |
| Katz, P | 1 |
| Criswell, LA | 1 |
| Yelin, E | 1 |
| Lander, SA | 1 |
| Weisman, MH | 1 |
| Poza-Guedes, P | 1 |
| González-Pérez, R | 1 |
| Canto, G | 1 |
| Yang, P | 1 |
| Zhang, Y | 1 |
| Ping, L | 1 |
| Gao, XM | 1 |
| Zhang, L | 1 |
| Bertucci, AM | 1 |
| Smith, KA | 1 |
| Xu, L | 1 |
| Datta, SK | 1 |
| Hachulla, E | 1 |
| Boyd, AS | 1 |
| King, LE | 1 |
2 reviews available for celecoxib and Libman-Sacks Disease
| Article | Year |
|---|---|
Celecoxib for systemic lupus erythematosus: case series and literature review of the use of NSAIDs in SLE.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Celecoxib; Cyclooxygenas | 2002 |
Celecoxib-induced lupus-like syndrome.
Topics: Aged; Antirheumatic Agents; Celecoxib; Cyclooxygenase Inhibitors; Female; Humans; Lupus Erythematosu | 2003 |
8 other studies available for celecoxib and Libman-Sacks Disease
| Article | Year |
|---|---|
Case report: Joint deformity associated with systemic lupus erythematosus.
Topics: Adult; Antibodies, Antinuclear; Antigens, Nuclear; Arthritis, Rheumatoid; C-Reactive Protein; Celeco | 2022 |
Clinical Significance of a Positive Antinuclear Antibody Test.
Topics: Adult; Antibodies, Antinuclear; Arthralgia; Autoantibodies; Biomarkers; Celecoxib; Cyclooxygenase 2 | 2015 |
Celecoxib for lupus.
Topics: Animals; Celecoxib; Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Humans; Lupus Erythematos | 2008 |
Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antirheumatic Agents; Biopsy; Celecoxib; Female; Follow | 2009 |
Apoptosis of murine lupus T cells induced by the selective cyclooxygenase-2 inhibitor celecoxib: molecular mechanisms and therapeutic potential.
Topics: Animals; Antibodies, Antinuclear; Apoptosis; Caspases; Celecoxib; Cells, Cultured; Cyclooxygenase 2 | 2007 |
Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus.
Topics: Administration, Oral; Animals; Antibodies, Antinuclear; Apoptosis; B-Lymphocytes; Celecoxib; Cycloox | 2007 |
[64th Congress of the American College of Rheumatology, Philadelphia, October 28-November 2, 2000].
Topics: Amyloidosis; Antiphospholipid Syndrome; Behcet Syndrome; Celecoxib; Cyclooxygenase Inhibitors; Giant | 2001 |
Middermal elastolysis in two patients with lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Celecoxib; Cutis Laxa; Derm | 2001 |